“These findings support the development of more accurate and personalized prognostic tools and gene-based therapies that improve the survival and quality of life of individuals afflicted by glioblastoma multiforme,” Serao concluded.
I found 705 clinical trials currently listed (Dec. 16, 2011) on the U. S. National Institutes of Health's registry at http://clinicaltrials.gov/ct2/results?term=glioblastoma/
1. National Brain Tumor Society. Web. Dec. 13, 2011.
2. Clarke J et al, “Recent advances in therapy for glioblastoma”, Archives of Neurology 2010; 67(3): 279-83.
3. Serao NVL et al, “Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival”, BMC Medical Genomics 2011; 4:49. http://www.ncbi.nlm.nih.gov/pubmed/21649900
Reviewed December 21, 2011
by Michele Blacksberg RN
Edited by Jody Smith